Viewing Study NCT01728259


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2025-12-26 @ 7:54 AM
Study NCT ID: NCT01728259
Status: TERMINATED
Last Update Posted: 2023-05-09
First Post: 2012-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module